PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

MGC Pharma

FEBRUARY 22, 2018

While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. It’s heartening to see the release of more and more evidence-based global research surrounding Medical Cannabis-based treatment.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. For too long, America has relied too heavily on opioids for pain relief. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MMJ Recs

FEBRUARY 18, 2024

These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders. One of the most well-known applications is pain relief, particularly for chronic pain, arthritis, and neuropathic pain.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

MMJ Recs

NOVEMBER 20, 2023

Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief. Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment.

Legislation 52

Legislation Law Marijuana Dispensary 52

MedicalJane

OCTOBER 28, 2022

Millions of Americans, especially older individuals, are turning to medical marijuana for managing their chronic pain symptoms. This increasing number of states that have legalized medical marijuana makes it easier for patients to obtain a prescription from their doctor, making it more accessible than ever before.

Chronic Pain 86

Chronic Pain Marijuana Medicine Pharmaceutical 86

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Veriheal

APRIL 21, 2022

So, let’s have a look at the current status of cannabis in New Zealand as well as this exciting new option for treatment. . ANTG has established a partnership with NUBU Pharmaceuticals which is New Zealand’s largest medicinal cannabis distributor. The Approved Cannabis Product in New Zealand.

Chronic Pain 95

Chronic Pain Pharmaceutical Medicine Patients 95

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Eric Rahn, Managing Director. Complicating matters, each state has their own set of laws, which are rapidly evolving.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland’s medical cannabis program.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 93

CBD Cannabinoids THC Extraction 93

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

MMJ Recs

JANUARY 22, 2024

This nuanced approach allows patients to customize their treatment, addressing specific symptoms or conditions without compromising mental clarity. CBD edibles, ranging from gummies to infused snacks, provide a discreet and precisely dosed method for individuals seeking relief from conditions such as anxiety, chronic pain, and insomnia.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

MMJ Recs

MAY 15, 2022

But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Medical marijuana products are produced and sold in Virginia by businesses called “pharmaceutical processors”. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Veriheal

AUGUST 13, 2020

THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronic pain. EPM-301 takes its name from the company EPM, a startup dedicated to bridging the gap between organic cannabis and the needs of pharmaceutical companies.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Once the card is issued, patients have access to the medicine through “facilities such as marijuana dispensaries, collectives, wellness centers, and clinics.”. I felt free from my ailment.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Weedistry

DECEMBER 29, 2018

Two years ago, the people of Florida overwhelmingly voted to approve Amendment 2, creating a constitutional right for those with medical conditions to seek treatment through medical marijuana. Most of the wave of incoming leaders after our recent midterm elections, at the state and federal level, support expanding access to medical marijuana.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. It’s an interesting analysis of who is using which strains to help treat which types of pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

MMJ Recs

NOVEMBER 7, 2022

A physical MMJ card is easily accessible, less prone to damage, and can be stored easily in your wallet. If the Registered Practitioner for Medical Cannabis decides you can benefit from medical marijuana treatment, they will write you a Certification for the Use of Medical Cannabis. Chronic Pain. Crohn’s Disease.

Marijuana 52

Marijuana Chronic Pain Dispensary Pharmaceutical 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Other common health problems include tinnitus, hearing loss, and lower-back pain. What is the VA’s Position of Medical Marijuana?

Access 49

Access Marijuana Research and Development Programs 49

MMJ Recs

JANUARY 17, 2024

Living with arthritis can be a daily battle against pain, inflammation, and stiffness. Traditional treatments may not always provide the desired relief, leading many individuals to explore alternative options like medical marijuana. Some states also require a registration fee.

Strains 98

Strains Marijuana Indica Microdosing 98

Cannabis Law Report

JANUARY 15, 2020

The fulfilment, which has been prescribed to Jorja Emerson, a three-year-old British girl who suffers from severe epilepsy, demonstrates a real progression in the quest to allow patients to access pioneering treatments of Medical Cannabis.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

The Cannigma

AUGUST 25, 2021

It’s important to note that Italy often suffers shortages in cannabis products, as that all medical cannabis prescribed in Italy must be produced by the Military Chemical Pharmaceutical Plant, or else imported from Canada or the Netherlands. Can foreigners access medical marijuana? How to get medical marijuana in Italy.

Legalization 52

Legalization Chronic Pain Decriminalization Conditions 52

Cannabis Law Report

DECEMBER 14, 2019

Upon receipt of a Controlled Drug License from the UK Home Office, after last week’s inspection, Farmako Limited will be fully licensed to pursue pharmaceutical/medical cannabis trading within the UK operating theatre. Recent UK legislation allows for the prescription of cannabis from medical specialists through a regular pharmacy model.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

PrestoDoctor

JUNE 7, 2023

They can reduce pain levels associated with migraines without producing unwanted side effects. This offers a natural, sustainable relief in place of pharmaceutical options like opioids or other medications. Finding effective migraine treatments can be complex and individualized. 1 in 7 individuals have experienced a migraine.

Research and Development 52

Research and Development Indica Strains Sleep 52

PrestoDoctor

JUNE 7, 2023

They can reduce pain levels associated with migraines without producing unwanted side effects. This offers a natural, sustainable relief in place of pharmaceutical options like opioids or other medications. Finding effective migraine treatments can be complex and individualized. 1 in 7 individuals have experienced a migraine.

Research and Development 52

Research and Development Indica Strains Sleep 52

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

FEBRUARY 3, 2022

The fast-acting, higher THC gummy provides significant relief to patients experiencing chronic pain, night terrors and other debilitating symptoms. As Texas physicians prescribe higher levels of THC, TXOG’s 20 mg gummies offer patients a more efficient treatment option to mitigate symptoms such as pain, spasticity, insomnia and nausea.

Chronic Pain 52

Chronic Pain THC Patients Cultivation 52

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

Veriheal

NOVEMBER 2, 2020

The Australian Department of Health and parliament have not established a list of qualifying conditions, but are currently looking into research for conditions commonly treated with cannabis such as chronic pain, epilepsy, and multiple sclerosis amongst others.

Chronic Pain 52

Chronic Pain Strains Conditions Patients 52

Cannabis Law Report

NOVEMBER 14, 2019

Barriers confronting patients trying to access medicinal cannabis in Australia will be scrutinised in a Parliamentary inquiry into how the drug is regulated. The Greens said the medicinal cannabis system is “broken” and in urgent need of reform as their push for an inquiry into access to the drug won support in the Senate on Thursday.

Access 49

Access Medicine Chronic Pain Patients 49

Cannabis Law Report

JANUARY 21, 2019

Britain tweaked legislation in November 2018 to allow specialist doctors in the UK to prescribe cannabis-based medicines to patients managing a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis.

Chronic Pain 72

Chronic Pain Medicine Education Patients 72